QLH12016
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for QLH12016, covering 2025-08-05 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer [Phase 1, Phase 2]